- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07665138
Sequence-Dependent Performance Adaptations Following Myofascial Chain Training in Youth Football Players
Sequence-Dependent Performance Adaptations Following Myofascial Chain Training in Youth Football Players: An Integrated Statistical and Knowledge Graph Approach
This study looked at whether the order of two different types of muscle-and-connective-tissue ("myofascial chain") training affects how young football players improve their jumping power and balance.
Forty male football players, aged 15 to 16, took part. Players were split into two groups by chance. One group did "posterior chain" training first, then switched to "spiral chain" training. The other group did the trainings in the opposite order. Each training phase lasted six weeks, and players kept doing their normal team practice at the same time.
Jumping power and balance were measured four times: before training started, after the first six weeks, after the second six weeks, and again four weeks after training ended.
The goal was to find out if starting with one type of training instead of the other leads to bigger, faster, or longer-lasting improvements. This information may help coaches design better training programs for young athletes.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Myofascial chains are interconnected lines of muscle and connective tissue that transmit force across body segments, contributing to movement efficiency, joint stability, and elastic energy storage. Among the chains described in fascial anatomy literature, the posterior chain is considered a primary contributor to explosive force production, while the spiral chain contributes to rotational control and dynamic balance. Despite growing interest in fascia-informed training approaches, no prior study has examined whether the sequence in which these chains are trained influences the magnitude, time-course, or persistence of performance adaptations in youth athletes.
To address this gap, the study employed a randomized crossover design. Participants were randomly allocated in a 1:1 ratio to one of two sequence groups: the Posterior Chain First Group (PCFG) or the Spiral Chain First Group (SCFG). Both groups continued their regular club training throughout the entire study period.
The intervention consisted of two consecutive six-week training blocks separated by a mid-test assessment. In the first block, each group performed their assigned myofascial chain protocol; following the crossover, groups switched protocols for the second block. Each training session lasted 30 minutes and was completed in addition to routine club practice. Outcomes were assessed at four time points - baseline, after the first block, after the second block, and at a four-week follow-up - to capture both the progression and persistence of adaptations.
The primary aim was to determine whether initiating training with the posterior chain versus the spiral chain produces differential adaptation trajectories, which may inform evidence-based sequencing decisions in youth athlete development programs.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Mersin
-
Mersin, Mersin, Turquie (Türkiye), 33343
- Mersin University
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
IInclusion Criteria:
- Male, aged 15-16 years (U15-U16 category)
- Holding an active football player license and currently competing with a club team
- Regularly participating in routine club training sessions
- Free from any injury or musculoskeletal condition that could affect performance testing at the time of enrollment
- Parental/legal guardian consent and participant assent obtained
Exclusion Criteria:
- Presence of any musculoskeletal injury, recent surgery, or medical condition affecting lower-limb function within the past 6 months
- Inability to attend the required training sessions or assessment time points
- Unwillingness or inability of parents/legal guardians to provide informed consent
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: PCFG (Posterior Chain First)
Participants performed a posterior chain-focused myofascial training protocol during the first 6-week period, followed by a spiral chain-focused protocol during the second 6-week period, in addition to routine club training.
|
A 6-week, twice-weekly structured training protocol targeting the posterior myofascial chain, consisting of a warm-up, five functional exercises, and a cool-down phase, delivered in addition to routine club training.
A 6-week, twice-weekly structured training protocol targeting the spiral myofascial chain, consisting of a warm-up, five functional exercises, and a cool-down phase, delivered in addition to routine club training.
|
|
Expérimental: SCFG (Spiral Chain First)
Participants performed a spiral chain-focused myofascial training protocol during the first 6-week period, followed by a posterior chain-focused protocol during the second 6-week period, in addition to routine club training.
|
A 6-week, twice-weekly structured training protocol targeting the posterior myofascial chain, consisting of a warm-up, five functional exercises, and a cool-down phase, delivered in addition to routine club training.
A 6-week, twice-weekly structured training protocol targeting the spiral myofascial chain, consisting of a warm-up, five functional exercises, and a cool-down phase, delivered in addition to routine club training.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Countermovement Jump (CMJ) Height
Délai: Measured at baseline (pre-test), 6 weeks (mid-test), 12 weeks (post-test), and 4 weeks post-test (follow-up)
|
Lower-limb explosive power was assessed using the countermovement jump, measured with a photocell device (SE-JP1).
Each participant performed three non-consecutive jumps with hands on hips, and the mean of the three trials was used for analysis.
|
Measured at baseline (pre-test), 6 weeks (mid-test), 12 weeks (post-test), and 4 weeks post-test (follow-up)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Dynamic Balance - YBT
Délai: Measured at baseline (pre-test), 6 weeks (mid-test), 12 weeks (post-test), and 4 weeks post-test (follow-up)
|
Dynamic balance was assessed using the Y-Balance Test with the right/left leg as the stance leg, measuring reach distance (cm) in the anterior, posteromedial, and posterolateral directions, normalized to leg length.
|
Measured at baseline (pre-test), 6 weeks (mid-test), 12 weeks (post-test), and 4 weeks post-test (follow-up)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- MEU-SBF-IK-01
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Délai de partage IPD
Critères d'accès au partage IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .